Stories about Health / Medicine
- 2more
New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
moreEleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...
moreGold Standard Diagnostics Europe
Novatec and Virotech to become Gold Standard Diagnostics Europe
Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...
moreePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon® E (Veregen®) at the 31st German Skin Cancer Congress on 10 September 2021
Strausberg (ots) - Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract "Inhibition of cell-proliferation and cell viability by Polyphenon E ® (Veregen®) in cutaneous SCC cell lines" has been accepted as an e-poster short presentation at the 31st German Skin Cancer Congress. In ...
more- 2
Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more M3 Invests in Physicians Career Portal praktischArzt
moreIntelligent algorithms for movement apps: with LTech, the Lindera Software Development Kit, Berlin-based health tech company Lindera brings innovation and AI technology to the fitness industry
moreSysmex Inostics presents data at ASCO
Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
moreDid my vaccine work? New rapid test for the determination of vaccination success
moreFluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test
moreSCHLUMBOHM Medizin-Labor-Technologie GmbH
2Worldwide sales of the new steam sterilizers and washer disinfectors from SCHLUMBOHM Medizin-Labor-Technologie GmbH to clinics, doctor's offices and laboratories.
moreFluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry
moreSysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...
moreIntroducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life
Berlin (ots) - The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with obesity a new way to find the right care. Adipositas Care thoughtfully empowers people living with obesity by enabling them to learn about obesity and discover possible ...
moreFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
moreHitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe (HMSE): The new "Plus" in human-centered open MRI is taking off at ECR 2021 with "SynergyDrive", the suite for streamlined workflow and high-speed exams
more- 2
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
more European Association of E-Pharmacies (EAEP)
EAEP as a Driving Force and Think Tank: European Association of Online Pharmacies Repositions Itself
Brussels/Berlin (ots) - The leading association of European online pharmacies has a new board team, a new name and a new external image: Walter Hess, Head Germany in the Group Management of the Zur Rose Group and CEO of DocMorris N.V., is now president of the association and Stefan Feltens, CEO SHOP APOTHEKE EUROPE, ...
moreEuropean Society for Medical Oncology (ESMO)
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research
moretFRWD LAUNCHES COVID-19 PCR SELF TEST TO DO AT HOME (SALIVA BASED)
Vienna (ots) - In partnership with local distributor DIVISIONCARE, tFRWD is ready to supply large numbers of the test-kits to the Portuguese. The test is done through RT.PCR and the kit is CE certified and approved by WHO with a sensitivity / specificity of 99%. This is the first Covid19 self-test solution to perform at home, completely painless, and without needing a health professional to collect the sample. Tester ...
moreIEVA (Independent European Vape Alliance)
Beating cancer with Harm Reduction
Bruxelles (ots) - The Independent European Vape Alliance (IEVA) welcomes and supports the “EU Beating Cancer Plan” presented today by the European Commission. The plan is extremely important in order to significantly reduce the number of cancer-related deaths. However, the new EU strategy neglects an important instrument for public health: Harm Reduction. Almost one third of cancer cases in Europe are caused by smoking: “Tobacco consumption continues to be the leading ...
moreProf. Dr. Heino Stöver - Sozialwissenschaftliche Suchtforschung
Expert for addiction studies, Prof. Dr. Heino Stöver, criticizes the new EU Beating Cancer Plan: "Target of less than 5 percent of smokers in the EU not achievable without harm reduction approach".
Frankfurt/Main (ots) - Prof. Dr. Heino Stöver has sharply criticized the EU Commission's "Beating Cancer Plan" presented today: "For years, the always same methods have been used trying to attain the ambitious goals of an almost tobacco-free continent. Tax increases, advertising bans and no-smoking zones are too ...
moreMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreIEVA (Independent European Vape Alliance)
E-Cigarettes flavours ban in the Netherlands endangers Public Health
Brussels (ots) - Around 65 percent of adult vapers in Europe use fruit or sweet liquids. [1] The variety of flavours is one of the most important reasons for smokers to switch to e-cigarettes and for vapers not to go back to smoking. Without paying attention to this fact, the Dutch State Secretary Paul Blokhuis has announced to ban all e-cigarette flavours except ...
moreCOVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease
Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...
moreCorona rapid test: Celebrate Christmas together without anyone getting infected
moreSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...
moreNew study: Only reliable rapid corona tests make sense
more